Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maíra Aguiar

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|May 10, 2018
Dengue vaccination: a more ethical approach is neededMaíra Aguiar
Physics of Life Reviews|March 8, 2011
The effect of global warming on vector-borne diseases: Comment on "Modeling the impact of global warming on vector-borne" infections by E. Massad et alMaíra Aguiar
Physics of Life Reviews|October 12, 2015
Scaling up complexity in host-pathogens interaction models: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et alMaíra Aguiar
The Lancet. Infectious Diseases|December 26, 2017
Dengvaxia: age as surrogate for serostatusMaíra Aguiar, Nico Stollenwerk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2017
Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent DataMaíra Aguiar, Nico Stollenwerk
Vaccines|November 17, 2020
The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case StudyMaíra Aguiar, Nico Stollenwerk
Royal Society Open Science|November 4, 2024
Modelling COVID-19 mutant dynamics: understanding the interplay between viral evolution and disease transmission dynamicsFernando Saldaña, Nico Stollenwerk, Maíra Aguiar
Plos Neglected Tropical Diseases|December 22, 2016
The Impact of the Newly Licensed Dengue Vaccine in Endemic CountriesMaíra Aguiar, Nico Stollenwerk, Scott B Halstead
Expert Review of Vaccines|December 25, 2016
Consider stopping dengvaxia administration without immunological screeningMaíra Aguiar, Scott B Halstead, Nico Stollenwerk
The Lancet. Infectious Diseases|August 2, 2016
The risks behind Dengvaxia recommendationMaíra Aguiar, Nico Stollenwerk, Scott B Halstead
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|May 10, 2018
Dengue vaccination: a more ethical approach is neededMaíra Aguiar
Physics of Life Reviews|March 8, 2011
The effect of global warming on vector-borne diseases: Comment on "Modeling the impact of global warming on vector-borne" infections by E. Massad et alMaíra Aguiar
Physics of Life Reviews|October 12, 2015
Scaling up complexity in host-pathogens interaction models: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et alMaíra Aguiar
The Lancet. Infectious Diseases|December 26, 2017
Dengvaxia: age as surrogate for serostatusMaíra Aguiar, Nico Stollenwerk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2017
Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent DataMaíra Aguiar, Nico Stollenwerk
Vaccines|November 17, 2020
The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case StudyMaíra Aguiar, Nico Stollenwerk
Royal Society Open Science|November 4, 2024
Modelling COVID-19 mutant dynamics: understanding the interplay between viral evolution and disease transmission dynamicsFernando Saldaña, Nico Stollenwerk, Maíra Aguiar
Plos Neglected Tropical Diseases|December 22, 2016
The Impact of the Newly Licensed Dengue Vaccine in Endemic CountriesMaíra Aguiar, Nico Stollenwerk, Scott B Halstead
Expert Review of Vaccines|December 25, 2016
Consider stopping dengvaxia administration without immunological screeningMaíra Aguiar, Scott B Halstead, Nico Stollenwerk
The Lancet. Infectious Diseases|August 2, 2016
The risks behind Dengvaxia recommendationMaíra Aguiar, Nico Stollenwerk, Scott B Halstead
Pageof 5